world
Zealand Pharma Shares Fall 20% After Weight-Loss Drug Trial Shows High Discontinuation Rate
The Danish company's stock dropped sharply Monday after trial participants discontinued use of its experimental weight-loss treatment at high rates.
MA
nbcnews.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Zealand Pharma shares fell by a fifth after trial participants stopped taking the company's experimental weight-loss drug at elevated rates. @MarketWatch reported the decline and the trial discontinuation in a single headline published on the current date of 2026-06-08. The stock reaction followed data showing many users gave up on the treatment during the study period.
No additional details on the size of the trial, specific discontinuation percentages, or company statements were included in the reporting.
Transparency
1 source · single source
CorroborationModerate · 1 source
